These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 553637)

  • 1. [Efficacy of a new beta-blocking drug (atenolol, ICI 66082) in treating arterial hypertension].
    Cerasola GA; Botta RM; Riolo A; Amico LM
    Boll Soc Ital Cardiol; 1979; 24(5):493-500. PubMed ID: 553637
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclothiazide and atenolol once daily in essential hypertension.
    Pitkäjärvi T
    Ann Clin Res; 1979 Feb; 11(1):1-8. PubMed ID: 378090
    [No Abstract]   [Full Text] [Related]  

  • 3. Atenolol in hypertension a study of long-term therapy.
    Zacharias FJ; Cowen KJ; Cuthbertson PF; Johnson TB; Prestt J; Thompson J; Vickers J; Simpson WT; Tuson R
    Postgrad Med J; 1977; 53 Suppl 3():102-10. PubMed ID: 928258
    [No Abstract]   [Full Text] [Related]  

  • 4. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
    Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
    Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
    Brandão AP; Oigman W; Albanesi Filho FM
    Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of penbutolol and atenolol in the therapy of essential hypertension].
    Fallo F; Pisani G; Mantero F
    Clin Ter; 1988 Jun; 125(6):425-30. PubMed ID: 2973948
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.
    Marshall AJ; Barritt DW; Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():168-72. PubMed ID: 337271
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of atenolol and propranolol in labile hypertension.
    González-Gómez A; Pérez-Medina T; Gamio-Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1979; 21(3):202-7. PubMed ID: 535405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical results of the combined use of a diuretic and a beta-blocking agent in the therapy of arterial hypertension].
    Allegri M; Magni S; Freggiaro V; Stirace T
    Clin Ter; 1982 Jan; 100(1):11-9. PubMed ID: 7151366
    [No Abstract]   [Full Text] [Related]  

  • 10. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 12. A new approach to drug trials in general practice. Comparison of the antihypertensive efficacy of metoprolol and atenolol.
    Adams-Strump BJ; Hayes J; Barber JH
    Practitioner; 1980 May; 224(1343):541-4. PubMed ID: 6999485
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical testing of a new beta blocking agent--atenolol--in hypertension].
    Hansson L; Henningsen NC; Jameson S; Karlberg BE; Westerlund A; Aberg H
    Lakartidningen; 1976 Aug; 73(34):2741-4. PubMed ID: 787700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of exercise tolerance in hypertensive patients treated with atenolol and methyldopa].
    Ambrosioni E; Costa FV; Agosta R; Magnani B
    G Clin Med; 1979 Aug; 60(8):676-83. PubMed ID: 398306
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. Evaluation with the bicycle ergometer].
    Mellini M; Robutti A; Mattiauda C; Cavazzana G; Roych C; Sanfelici D; Baccino M; Reforzo F
    Clin Ter; 1983 Mar; 104(5):391-4. PubMed ID: 6851445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of atenolol in the ambulatory treatment of arterial hypertension].
    Demczuk M; Marszal-Marciniak M; Rafalska K; Krzemińska-Pakuła M
    Kardiol Pol; 1982; 25(7-8):533-9. PubMed ID: 6763100
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of a single daily dose of atenolol (tenormin) on arterial hypertension].
    Ramírez-Rubio B; García Betancourt L; Piñeyro A; Cardona M; Galarza M
    Prensa Med Mex; 1978; 43(7-8):256-7. PubMed ID: 392492
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long term effects of the beta-adrenergic blocking agent atenolol (Tenormin) on coronary heart disease: a study of 125 patients (author's transl)].
    Langbehn AF; Burmeister G; Horst H; Sonntag F; Klempien EJ
    Med Klin; 1978 Jan; 73(3):101-5. PubMed ID: 622059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hypertension with tenormin 100 (atenolol). A general practice study (author's transl)].
    Hiemstra S; Ziegler E
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1777-80. PubMed ID: 6779149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.